ArticleFrontiers in pharmacology2024

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study.

Jingying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.